Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Cognitive validation of cross-diagnostic cognitive subgroups on the schizophrenia-bipolar spectrum.

Karantonis JA, Rossell SL, Carruthers SP, Sumner P, Hughes M, Green MJ, Pantelis C, Burdick KE, Cropley V, Van Rheenen TE.

J Affect Disord. 2020 Jan 25;266:710-721. doi: 10.1016/j.jad.2020.01.123. [Epub ahead of print]

PMID:
32056949
2.

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.

Pettitt AR, Jackson R, Cicconi S, Polydoros F, Yap C, Dodd J, Bickerstaff M, Stackpoole M, Khan UT, Carruthers S, Oates M, Lin K, Coupland SE, Menon G, Kalakonda N, McCarthy H, Bloor A, Schuh A, Duncombe A, Dearden C, Fegan C, Kennedy B, Walewska R, Marshall S, Fox CP, Hillmen P.

Haematologica. 2020 Feb 13. pii: haematol.2019.230805. doi: 10.3324/haematol.2019.230805. [Epub ahead of print] No abstract available.

3.

Beyond intervention into daily life: A systematic review of generalisation following social communication interventions for young children with autism.

Carruthers S, Pickles A, Slonims V, Howlin P, Charman T.

Autism Res. 2020 Jan 14. doi: 10.1002/aur.2264. [Epub ahead of print] Review.

PMID:
31943828
4.

The influence of gender on emotional aspects of auditory verbal hallucinations.

Toh WL, Gurvich C, Thomas N, Tan EJ, Neill E, Van Rheenen T, Sumner PJ, Carruthers SP, Thomas EH, Hughes ME, Michie PT, Rossell SL.

Psychiatry Res. 2020 Feb;284:112642. doi: 10.1016/j.psychres.2019.112642. Epub 2019 Oct 28. No abstract available.

PMID:
31706590
5.

Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.

Henderson MA, Gyorki D, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.

Ann Surg Oncol. 2019 Dec;26(13):4663-4672. doi: 10.1245/s10434-019-07810-0. Epub 2019 Sep 12.

PMID:
31515719
6.

Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis.

Carruthers SP, Van Rheenen TE, Gurvich C, Sumner PJ, Rossell SL.

Neurosci Biobehav Rev. 2019 Dec;107:252-278. doi: 10.1016/j.neubiorev.2019.09.006. Epub 2019 Sep 7. Review.

PMID:
31505202
7.

Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial - Corrigendum.

Bryce SD, Rossell SL, Lee SJ, Lawrence RJ, Tan EJ, Carruthers SP, Ponsford JL.

J Int Neuropsychol Soc. 2019 Jul;25(6):659-660. doi: 10.1017/S1355617719000535. No abstract available.

PMID:
31290385
8.

Exploring Heterogeneity on the Wisconsin Card Sorting Test in Schizophrenia Spectrum Disorders: A Cluster Analytical Investigation.

Carruthers SP, Gurvich CT, Meyer D; Australian Schizophrenia Research Bank, Bousman C, Everall IP, Neill E, Pantelis C, Sumner PJ, Tan EJ, Thomas EHX, Van Rheenen TE, Rossell SL.

J Int Neuropsychol Soc. 2019 Aug;25(7):750-760. doi: 10.1017/S1355617719000420.

PMID:
31104647
9.

Measuring (and narrowing) the gap: The experience with attendance of Indigenous cancer patients for Radiation Therapy in the Northern Territory.

Carruthers S, Pennefather M, Ward L, Giam K, Penniment M.

J Med Imaging Radiat Oncol. 2019 Aug;63(4):510-516. doi: 10.1111/1754-9485.12887. Epub 2019 May 13.

PMID:
31081995
10.

The effects of a muscarinic receptor 1 gene variant on executive and non-executive cognition in schizophrenia spectrum disorders.

Carruthers SP, Cropley V, Bousman C, Everall IP, Neill E, Pantelis C, Sumner PJ, Tan EJ; Australian Schizophrenia Research Bank, Bozaoglu K, Thomas EHX, Van Rheenen TE, Gurvich CT, Rossell SL.

Psychiatry Res. 2019 Mar;273:178-180. doi: 10.1016/j.psychres.2019.01.032. Epub 2019 Jan 11.

PMID:
30654302
11.

Working Memory and Attention Influence Antisaccade Error Rate in Schizophrenia.

Thomas EHX, Rossell SL, Myles JB, Tan EJ, Neill E, Carruthers SP, Sumner PJ, Bozaoglu K, Gurvich C.

J Int Neuropsychol Soc. 2018 Dec 18:1-10. doi: 10.1017/S1355617718001066. [Epub ahead of print]

PMID:
30558685
12.

A cross-cultural study of autistic traits across India, Japan and the UK.

Carruthers S, Kinnaird E, Rudra A, Smith P, Allison C, Auyeung B, Chakrabarti B, Wakabayashi A, Baron-Cohen S, Bakolis I, Hoekstra RA.

Mol Autism. 2018 Nov 5;9:52. doi: 10.1186/s13229-018-0235-3. eCollection 2018.

13.

Brief Report: Testing the Psychometric Properties of the Spence Children's Anxiety Scale (SCAS) and the Screen for Child Anxiety Related Emotional Disorders (SCARED) in Autism Spectrum Disorder.

Carruthers S, Kent R, Hollocks MJ, Simonoff E.

J Autism Dev Disord. 2018 Oct 17. doi: 10.1007/s10803-018-3774-8. [Epub ahead of print]

PMID:
30334126
14.

The effects of a muscarinic receptor 1 gene variant on cortical thickness and surface area in schizophrenia.

Carruthers SP, Gurvich CT, Cropley VL, Pantelis C, Bousman C, Lenroot RK, Bruggemann JM, Weickert T; Australian Schizophrenia Research Bank, Rossell SL.

Psychiatry Res Neuroimaging. 2018 Oct 30;280:62-64. doi: 10.1016/j.pscychresns.2018.08.014. Epub 2018 Aug 24.

PMID:
30173002
15.

White matter microstructure in anorexia nervosa.

Phillipou A, Carruthers SP, Di Biase MA, Zalesky A, Abel LA, Castle DJ, Gurvich C, Rossell SL.

Hum Brain Mapp. 2018 Nov;39(11):4385-4392. doi: 10.1002/hbm.24279. Epub 2018 Jul 2.

PMID:
29964345
16.

Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry.

Tapia Rico G, Karapetis C, Townsend AR, Piantadosi C, Padbury R, Roy A, Maddern G, Moore J, Carruthers S, Roder D, Price TJ.

Acta Oncol. 2018 Nov;57(11):1455-1457. doi: 10.1080/0284186X.2018.1473640. Epub 2018 May 18. No abstract available.

PMID:
29775123
17.

Do schizotypy dimensions reflect the symptoms of schizophrenia?

Thomas EH, Rossell SL, Tan EJ, Neill E, Van Rheenen TE, Carruthers SP, Sumner PJ, Louise S, Bozaoglu K, Gurvich C.

Aust N Z J Psychiatry. 2019 Mar;53(3):236-247. doi: 10.1177/0004867418769746. Epub 2018 Apr 28.

PMID:
29707955
18.

Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry.

Tapia Rico G, Price TJ, Karapetis C, Piantadosi C, Padbury R, Roy A, Maddern G, Moore J, Carruthers S, Roder D, Townsend AR.

Cancer Biol Med. 2017 Nov;14(4):371-376. doi: 10.20892/j.issn.2095-3941.2017.0068.

19.

Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial.

Bryce SD, Rossell SL, Lee SJ, Lawrence RJ, Tan EJ, Carruthers SP, Ponsford JL.

J Int Neuropsychol Soc. 2018 Jul;24(6):549-562. doi: 10.1017/S1355617717001369. Epub 2018 Jan 21. Erratum in: J Int Neuropsychol Soc. 2019 Jul;25(6):659-660.

PMID:
29352823
20.

Prospective randomized trial of neoadjuvant chemotherapy during the 'wait period' following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial.

Moore J, Price T, Carruthers S, Selva-Nayagam S, Luck A, Thomas M, Hewett P.

Colorectal Dis. 2017 Nov;19(11):973-979. doi: 10.1111/codi.13724.

PMID:
28503826
21.

Childhood trauma exposure in substance use disorder patients with and without ADHD.

Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MW, van den Brink W.

Addict Behav. 2017 Feb;65:118-124. doi: 10.1016/j.addbeh.2016.10.016. Epub 2016 Oct 24. No abstract available.

22.

Efficient identification of CRISPR/Cas9-induced insertions/deletions by direct germline screening in zebrafish.

Brocal I, White RJ, Dooley CM, Carruthers SN, Clark R, Hall A, Busch-Nentwich EM, Stemple DL, Kettleborough RN.

BMC Genomics. 2016 Mar 24;17:259. doi: 10.1186/s12864-016-2563-z.

23.

Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers.

Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MWJ, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W.

J Atten Disord. 2019 Oct;23(12):1438-1453. doi: 10.1177/1087054716629217. Epub 2016 Feb 27.

24.

High-throughput and quantitative genome-wide messenger RNA sequencing for molecular phenotyping.

Collins JE, Wali N, Sealy IM, Morris JA, White RJ, Leonard SR, Jackson DK, Jones MC, Smerdon NC, Zamora J, Dooley CM, Carruthers SN, Barrett JC, Stemple DL, Busch-Nentwich EM.

BMC Genomics. 2015 Aug 5;16:578. doi: 10.1186/s12864-015-1788-6.

25.

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

Henderson MA, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.

Lancet Oncol. 2015 Sep;16(9):1049-1060. doi: 10.1016/S1470-2045(15)00187-4. Epub 2015 Jul 20.

PMID:
26206146
26.

The muscarinic system, cognition and schizophrenia.

Carruthers SP, Gurvich CT, Rossell SL.

Neurosci Biobehav Rev. 2015 Aug;55:393-402. doi: 10.1016/j.neubiorev.2015.05.011. Epub 2015 May 21. Review.

PMID:
26003527
27.

Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.

Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F; IASP Research Group.

Eur Addict Res. 2015;21(4):188-94. doi: 10.1159/000371724. Epub 2015 Apr 1.

28.

Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?

Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MWJ, van den Brink W, Moggi F, Møller M, van de Glind G.

Addict Behav Rep. 2015 Mar 28;2:13-18. doi: 10.1016/j.abrep.2015.03.001. eCollection 2015 Dec.

29.

Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.

Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D.

Drug Alcohol Rev. 2015 Nov;34(6):683-93. doi: 10.1111/dar.12249. Epub 2015 Mar 18.

PMID:
25790353
30.

Xenopus mutant reveals necessity of rax for specifying the eye field which otherwise forms tissue with telencephalic and diencephalic character.

Fish MB, Nakayama T, Fisher M, Hirsch N, Cox A, Reeder R, Carruthers S, Hall A, Stemple DL, Grainger RM.

Dev Biol. 2014 Nov 15;395(2):317-330. doi: 10.1016/j.ydbio.2014.09.004. Epub 2014 Sep 16.

31.

Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.

Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W.

Drug Alcohol Depend. 2014 Nov 1;144:70-7. doi: 10.1016/j.drugalcdep.2014.08.008. Epub 2014 Aug 26.

PMID:
25193717
32.

Oseltamivir use amongst hospitalized patients infected with influenza.

Herman M, Smieja M, Carruthers S, Loeb M.

Influenza Other Respir Viruses. 2014 Sep;8(5):547-8. doi: 10.1111/irv.12260. Epub 2014 Jul 4. No abstract available.

33.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

34.

External evaluation of the Radiation Therapy Oncology Group brachial plexus contouring protocol: several issues identified.

Min M, Roos D, Keating E, Penniment M, Carruthers S, Zanchetta L, Wong K, Shakeshaft J, Baxi S.

J Med Imaging Radiat Oncol. 2014;58(3):360-8. doi: 10.1111/1754-9485.12175. Epub 2014 Apr 9.

35.

A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.

Yap L, Carruthers S, Thompson S, Cheng W, Jones J, Simpson P, Richards A, Thein HH, Haber P, Lloyd A, Butler T.

PLoS One. 2014 Feb 27;9(2):e87564. doi: 10.1371/journal.pone.0087564. eCollection 2014.

36.

Control processes in voluntary and explicitly cued task switching.

Masson ME, Carruthers S.

Q J Exp Psychol (Hove). 2014 Oct;67(10):1944-58. doi: 10.1080/17470218.2013.879390. Epub 2014 Mar 5.

PMID:
24443883
37.

Obstetric and neonatal outcomes for women ≥ 45 years of age: a cohort study.

McDonnell NA, Walsh JM, Carruthers SC, Morrison JJ.

Am J Perinatol. 2014 Oct;31(9):823-8. doi: 10.1055/s-0033-1361932. Epub 2013 Dec 12.

PMID:
24338131
38.

The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.

Nielsen S, Bruno R, Degenhardt L, Stoove MA, Fischer JA, Carruthers SJ, Lintzeris N.

Med J Aust. 2013 Nov 18;199(10):696-9.

PMID:
24237102
39.

Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.

van de Glind G, Konstenius M, Koeter MWJ, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P; IASP Research Group, Levin FR, van den Brink W.

Drug Alcohol Depend. 2014 Jan 1;134:158-166. doi: 10.1016/j.drugalcdep.2013.09.026. Epub 2013 Oct 5.

40.

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S; IASP research group, van den Brink W, Schoevers RA.

Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20.

41.

The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.

van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Allsop S, Carruthers S, Schoevers RA; Iasp Research Group, van den Brink W.

Int J Methods Psychiatr Res. 2013 Sep;22(3):232-44. doi: 10.1002/mpr.1397. Epub 2013 Sep 11.

42.

Magno- and Parvocellular Contrast Responses in Varying Degrees of Autistic Trait.

Jackson BL, Blackwood EM, Blum J, Carruthers SP, Nemorin S, Pryor BA, Sceneay SD, Bevan S, Crewther DP.

PLoS One. 2013 Jun 18;8(6):e66797. doi: 10.1371/journal.pone.0066797. Print 2013.

43.

Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.

van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA; IASP Research Group, Levin FR.

Drug Alcohol Depend. 2013 Oct 1;132(3):587-96. doi: 10.1016/j.drugalcdep.2013.04.010. Epub 2013 May 6.

44.

A systematic genome-wide analysis of zebrafish protein-coding gene function.

Kettleborough RN, Busch-Nentwich EM, Harvey SA, Dooley CM, de Bruijn E, van Eeden F, Sealy I, White RJ, Herd C, Nijman IJ, Fényes F, Mehroke S, Scahill C, Gibbons R, Wali N, Carruthers S, Hall A, Yen J, Cuppen E, Stemple DL.

Nature. 2013 Apr 25;496(7446):494-7. doi: 10.1038/nature11992. Epub 2013 Apr 17.

45.

Radiation treatment compliance in the Indigenous population: the pilot Northern Territory experience and future directions.

Le H, Penniment M, Carruthers S, Roos D, Sullivan T, Baxi S.

J Med Imaging Radiat Oncol. 2013 Apr;57(2):218-21. doi: 10.1111/1754-9485.12010. Epub 2013 Mar 26.

PMID:
23551784
46.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
47.

'The challenge is massive'. Interview by Daloni Carlisle.

Carruthers SI.

Health Serv J. 2012 May 31;122(6308):Suppl 10-1. No abstract available.

PMID:
22950171
48.

Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.

Khattak MA, Martin HL, Beeke C, Price T, Carruthers S, Kim S, Padbury R, Karapetis CS.

Clin Colorectal Cancer. 2012 Dec;11(4):247-54. doi: 10.1016/j.clcc.2012.06.004. Epub 2012 Jul 3.

PMID:
22763194
49.

Reducing alcohol use during pregnancy: listening to women who drink as an intervention starting point.

McBride N, Carruthers S, Hutchinson D.

Glob Health Promot. 2012 Jun;19(2):6-18. doi: 10.1177/1757975912441225. Epub 2012 May 4.

PMID:
24801778
50.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447

Supplemental Content

Loading ...
Support Center